#cancer research

An example of collaborative science in Office of Cancer Genomics programs

NCI director Norman Sharpless shares his vision at American Association for Cancer Research annual meeting.

Immunotherapy lowered the likelihood of relapse after surgery.

Dream Team aims to replace “watch and wait” with effective treatments.

It’s a privilege to help advance cancer research and care that directly benefits American active-duty military and veterans.

The analysis gives cancer researchers “unprecedented understanding of how, where and why tumors arise in humans.”

FDA will work in close partnership with patients to incorporate their experience into benefit-risk assessments.

Research studies are often built around an educated guess. What happens when those guesses are wrong?

Who better than physician-scientists to understand the urgent needs of cancer patients for new treatments and push that research in the lab?

’Cystine-dense peptides’ are a largely untapped source of new therapeutics for tough diseases

The article features four women whose rare, aggressive ovarian cancers were unexpectedly cured with immunotherapy.

Recent studies of a genetically-engineered cold virus on brain tumor growth suggest huge promise for new cancer immunotherapies.

The hairless rodents’ genes give them superlong life spans and a remarkable resistance to age-related diseases.

Our lives and the lives of future generations depend on it.

Jim Wells, PhD, discusses how his mentorship at Damon Runyon shaped his own career and why he brings Damon Runyon fellows into his lab.

A connection between water fluoridation and cancer would be detectable—but in more than 50 studies, no connection has been found